+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Smart Pills - Global Strategic Business Report

  • PDF Icon

    Report

  • 196 Pages
  • April 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5140163

Global Smart Pills Market to Reach $948.4 Million by 2030

The global market for Smart Pills estimated at US$396.4 Million in the year 2022, is projected to reach a revised size of US$948.4 Million by 2030, growing at a CAGR of 11.5% over the analysis period 2022-2030. Esophagus, one of the segments analyzed in the report, is projected to record 12.1% CAGR and reach US$219 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Small Intestine segment is readjusted to a revised 12.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $119.1 Million, While China is Forecast to Grow at 10.9% CAGR

The Smart Pills market in the U.S. is estimated at US$119.1 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$163 Million by the year 2030 trailing a CAGR of 10.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.1% and 9.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR.

Select Competitors (Total 46 Featured) -

  • Capsovision, Inc.
  • Check-Cap Ltd.
  • Hq, Inc.
  • IntroMedic
  • Jinshan Science & Technology (Group) Co., Ltd.
  • Koninklijke Philips NV
  • Medtronic PLC
  • Olympus Corporation
  • Proteus Digital Health, Inc.
  • RF Co., Ltd.

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Smart Pills - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Smart Pills by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 2: World 8-Year Perspective for Smart Pills by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
  • Table 3: World Recent Past, Current & Future Analysis for Esophagus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 4: World 8-Year Perspective for Esophagus by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Small Intestine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 6: World 8-Year Perspective for Small Intestine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Large Intestine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 8: World 8-Year Perspective for Large Intestine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 9: World Recent Past, Current & Future Analysis for Stomach by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 10: World 8-Year Perspective for Stomach by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Capsule Endoscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 12: World 8-Year Perspective for Capsule Endoscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 14: World 8-Year Perspective for Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 15: World Recent Past, Current & Future Analysis for Patient Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 16: World 8-Year Perspective for Patient Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 18: World 8-Year Perspective for Hospital by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Diagnostic Center by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 20: World 8-Year Perspective for Diagnostic Center by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 21: World Recent Past, Current & Future Analysis for Research Institute by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 22: World 8-Year Perspective for Research Institute by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 23: World Smart Pills Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
  • UNITED STATES
  • Smart Pills Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 24: USA Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 25: USA 8-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2023 & 2030
  • Table 26: USA Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 27: USA 8-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2023 & 2030
  • Table 28: USA Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 29: USA 8-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2023 & 2030
  • CANADA
  • Table 30: Canada Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 31: Canada 8-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2023 & 2030
  • Table 32: Canada Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 33: Canada 8-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2023 & 2030
  • Table 34: Canada Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 35: Canada 8-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2023 & 2030
  • JAPAN
  • Smart Pills Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 36: Japan Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 37: Japan 8-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2023 & 2030
  • Table 38: Japan Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 39: Japan 8-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2023 & 2030
  • Table 40: Japan Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 41: Japan 8-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2023 & 2030
  • CHINA
  • Smart Pills Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 42: China Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 43: China 8-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2023 & 2030
  • Table 44: China Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 45: China 8-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2023 & 2030
  • Table 46: China Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 47: China 8-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2023 & 2030
  • EUROPE
  • Smart Pills Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 48: Europe Recent Past, Current & Future Analysis for Smart Pills by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 49: Europe 8-Year Perspective for Smart Pills by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
  • Table 50: Europe Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 51: Europe 8-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2023 & 2030
  • Table 52: Europe Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 53: Europe 8-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2023 & 2030
  • Table 54: Europe Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 55: Europe 8-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2023 & 2030
  • FRANCE
  • Smart Pills Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 56: France Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 57: France 8-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2023 & 2030
  • Table 58: France Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 59: France 8-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2023 & 2030
  • Table 60: France Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 61: France 8-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2023 & 2030
  • GERMANY
  • Smart Pills Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 62: Germany Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 63: Germany 8-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2023 & 2030
  • Table 64: Germany Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 65: Germany 8-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2023 & 2030
  • Table 66: Germany Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 67: Germany 8-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2023 & 2030
  • ITALY
  • Table 68: Italy Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 69: Italy 8-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2023 & 2030
  • Table 70: Italy Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 71: Italy 8-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2023 & 2030
  • Table 72: Italy Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 73: Italy 8-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2023 & 2030
  • UNITED KINGDOM
  • Smart Pills Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 74: UK Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 75: UK 8-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2023 & 2030
  • Table 76: UK Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 77: UK 8-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2023 & 2030
  • Table 78: UK Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 79: UK 8-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2023 & 2030
  • REST OF EUROPE
  • Table 80: Rest of Europe Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 81: Rest of Europe 8-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2023 & 2030
  • Table 82: Rest of Europe Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 83: Rest of Europe 8-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2023 & 2030
  • Table 84: Rest of Europe Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 85: Rest of Europe 8-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2023 & 2030
  • ASIA-PACIFIC
  • Smart Pills Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 86: Asia-Pacific Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 87: Asia-Pacific 8-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2023 & 2030
  • Table 88: Asia-Pacific Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 89: Asia-Pacific 8-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2023 & 2030
  • Table 90: Asia-Pacific Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 91: Asia-Pacific 8-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2023 & 2030
  • REST OF WORLD
  • Table 92: Rest of World Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 93: Rest of World 8-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2023 & 2030
  • Table 94: Rest of World Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 95: Rest of World 8-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2023 & 2030
  • Table 96: Rest of World Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 97: Rest of World 8-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2023 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Capsovision, Inc.
  • Check-Cap Ltd.
  • Hq, Inc.
  • IntroMedic
  • Jinshan Science & Technology (Group) Co., Ltd.
  • Koninklijke Philips NV
  • Medtronic PLC
  • Olympus Corporation
  • Proteus Digital Health, Inc.
  • RF Co., Ltd.

Table Information